Exodus Point Capital Management, LP Shattuck Labs, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding STTK
# of Institutions
75Shares Held
31.4MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$5.11 Million2.39% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$4.27 Million0.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$3.6 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$1.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$1.85 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $32.6M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...